Nearly 50 patients per months are tested at Nanjing Medical Technology Innovation Center to achieve individualized medical treatment

The Center, operated by Southern Medical University and the District Government, is targeting genes related to breast, lung, prostate and ovarian cancers, followed by a patient-specific use of antitumor drugs.

China Bio news release, October 13, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny